SPOTLIGHT: Celtic, Inspiration strike collaboration

Celtic Pharma and Inspiration Biopharmaceuticals announced a collaboration--valued at up to $35 million--intended to enhance the development of Inspiration's Factor IX for the treatment of Hemophilia B. Release